missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LMBR1L Polyclonal Antibody
Rabbit Polyclonal Antibody
Marque: Invitrogen™ PA526795
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
LMBR1L Polyclonal Antibody for Western Blot, IHC (P), Flow
LMBR1L, also known as LIMR (lipocalin-1-interacting membrane receptor), interacts with lipocalin-1 (Lcn-1), a lipocalin member produced by a number of secretory glands and tissues and known to bind a variety of lipophilic compounds. LMBR1L is a 489-amino acid protein with a predicted molecular mass of 55 kDa and 9 putative transmembrane helices. LMBR1L has been shown to mediate cellular uptake of LMBR1L, thus it is characterized as a endocytic receptor. Alternatively spliced transcript variants encoding different isoforms have been described.
Spécification
LMBR1L | |
Polyclonal | |
Unconjugated | |
LMBR1L | |
1110013E13Rik; AA415653; D15Ertd735e; KIAA1174; limb development membrane protein 1 like; limb development membrane protein 1-like; limb region 1 homolog-like; limb region 1 like; limb region 1 protein homolog-like; limb region 1-like homolog; limb region 1-like protein -like; LIMR; lipocalin-1 interacting membrane receptor; lipocalin-1-interacting membrane receptor; lipocalin-interacting membrane receptor; Lmbr1l; Protein LMBR1L; RGD1309631; UNQ458/PRO783; Uteroglobin receptor | |
Rabbit | |
Antigen Affinity Chromatography, Protein A | |
RUO | |
55716 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
0.5 mg/mL | |
PBS with 0.09% sodium azide; pH 7.4 | |
Q6UX01 | |
LMBR1L | |
KLH conjugated synthetic peptide between 462-489 amino acids from the C-terminal region of human LMBR1L. | |
400 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu